Finance

Lists
543828:BOM
Sudarshan Pharma Industries Ltd
₹36,25
-1,33%
(-0,49) 1D
15 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 543828...
Open
₹37,01
High
₹37,55
Low
₹36,20
Mkt. cap
9,22 mjd
Avg. vol.
411,60 k
Volume
40,00 k
P/E ratio
34,94
52-wk high
₹42,79
52-wk low
₹18,50
EPS
₹1,04
No. of employees
64
Open
₹37,01
High
₹37,55
Low
₹36,20
Mkt. cap
9,22 mjd
Avg. vol.
411,60 k
Volume
40,00 k
P/E ratio
34,94
52-wk high
₹42,79
52-wk low
₹18,50
EPS
₹1,04
No. of employees
64
News stories
From web sources and news partners
About Sudarshan Pharma Industries Ltd
CEO-
Employees64
Founded2008
Headquarters-
SectorSpeciality chemicals
Websitesudarshanpharma.com
Last report
12 Aug. 2026
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
1,74 mjd / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,69 mjd
1,68 mjd
2,21 mjd
1,74 mjd
Cost of goods sold
1,52 mjd
1,48 mjd
1,90 mjd
1,50 mjd
Cost of revenue
1,52 mjd
1,48 mjd
1,90 mjd
1,50 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17,78 m
19,74 m
33,01 m
20,68 m
Operating expense
82,51 m
102,47 m
106,15 m
101,78 m
Total operating expenses
1,61 mjd
1,58 mjd
2,01 mjd
1,60 mjd
Operating income
83,02 m
99,60 m
200,65 m
144,93 m
Other non operating income
18,63 m
15,18 m
-49,24 m
12,20 m
EBT including unusual items
42,28 m
51,98 m
157,04 m
75,05 m
EBT excluding unusual items
42,28 m
51,98 m
146,84 m
75,05 m
Income tax expense
3,56 m
10,50 m
43,12 m
18,96 m
Effective tax rate
8,41%
20,20%
27,46%
25,26%
Other operating expenses
55,72 m
73,62 m
62,22 m
67,03 m
Net income
41,83 m
43,57 m
107,26 m
58,55 m
Net profit margin
2,48%
2,59%
4,86%
3,36%
Earnings per share
-
-
-
-
Interest and investment income
-
-
20,21 m
-
Interest expense
-59,38 m
-62,79 m
-46,82 m
-82,07 m
Net interest expenses
-59,38 m
-62,79 m
-26,61 m
-82,07 m
Depreciation and amortization charges
9,01 m
9,11 m
10,93 m
14,06 m
EBITDA
91,95 m
102,17 m
206,78 m
154,40 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme